Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 25, 2016

Effect of intramuscular cholecalciferol megadose in children with nutritional rickets

  • Meenakshi Bothra , Nandita Gupta and Vandana Jain EMAIL logo

Abstract

Background: The treatment practices for vitamin D deficiency rickets are highly variable. Though a single intramuscular (IM) megadose of vitamin D is economical, and ensures good compliance, it poses the risk of hypervitaminosis D. This observational study was conducted to assess the duration of effect and safety of single IM megadose of cholecalciferol in the treatment of vitamin D deficiency rickets.

Methods: Children younger than 14 years with rickets were enrolled. Baseline investigations included radiograph of wrists and estimation of serum calcium, phosphate, alkaline phosphatase (ALP), 25(OH) vitamin D and parathormone (PTH) levels. All children received a single IM megadose of vitamin D3. Biochemical parameters were re-evaluated at 1.5, 3 and 6 months after the megadose and the values were compared to the baseline.

Results: We enrolled 21 children, out of which nine remained under active follow-up till 6 months. Radiological evidence of rickets was present in all 21 children, 14 had hypocalcemia at the time of presentation. After IM cholecalciferol megadose, median 25 hydroxy vitamin D [25(OH)D] level remained significantly more than the baseline till 6 months after the megadose. At 1.5 months after the vitamin D megadose, three (30%) of the children were found to develop toxic levels of vitamin D (>150 ng/mL), although none had hypercalcemia or any clinical manifestation of vitamin D toxicity. At 3 months and 6 months after the megadose, 25(OH)D levels remained in the sufficient range (20–100 ng/mL) in seven out of the eight children who came for follow-up.

Conclusions: A single IM megadose of vitamin D may be effective in significantly increasing the 25(OH)D levels for at least 6 months in children with rickets, but elevation of 25(OH)D to toxic range raises concern regarding its safety.


Corresponding author: Vandana Jain, Additional Professor, All India Institute of Medical Sciences, Division of Pediatric Endocrinology, Department of Pediatrics, Ansari Nagar, New Delhi-110029, India, Phone: +11 26594345, E-mail:

References

1. Dimitri P, Bishop N. Rickets. Paediatr Child Health 2007;17: 279–87.10.1016/j.paed.2007.04.004Search in Google Scholar

2. Tiwari L, Puliyel JM. Vitamin D level in slum children of Delhi. Indian Pediatr 2004;41:1076–7.Search in Google Scholar

3. Jain V, Gupta N, Kalaivani M, Jain A, Sinha A, et al. Vitamin D deficiency in healthy breastfed term infants at 3 months & their mothers in India: seasonal variation & determinants. Indian J Med Res 2011;133:267–73.Search in Google Scholar

4. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062–72.10.1172/JCI29449Search in Google Scholar

5. Shah BR, Finberg L. Single-day therapy for nutritional vitamin D-deficiency rickets: a preferred method. J Pediatr 1994;125:487–90.10.1016/S0022-3476(05)83303-7Search in Google Scholar

6. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266–81.10.1056/NEJMra070553Search in Google Scholar

7. Cesur Y, Caksen H, Gundem A, Kirimi E, Odabas D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab 2003;16:1105–9.10.1515/JPEM.2003.16.8.1105Search in Google Scholar

8. Mimouni F. Single-day therapy for rickets. J Pediatr 1995;126:1019–20.10.1016/S0022-3476(95)70242-3Search in Google Scholar

9. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122;398.10.1542/peds.2007-1894Search in Google Scholar PubMed

10. Souberbielle JC, Lawson-Body E, Hammadi B, Sarfati E, Kahan A, et al. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab 2003;88:3501–4.10.1210/jc.2003-030097Search in Google Scholar PubMed

11. Kliegman R, Jenson H, Behrman R, Stanton B. Nelson textbook of pediatrics, 18th ed. Philadelphia: Elsevier, 2011:288.Search in Google Scholar

12. Arcara K, Tschudy M. The harriet lane handbook, 19th ed. United States of America: Elsevier.Search in Google Scholar

13. Mondal K, Seth A, Marwaha RK, Dhanwal D, Aneja S, et al. A Randomized controlled trial on safety and efficacy of single intramuscular versus staggered oral dose of 600 000IU Vitamin D in treatment of nutritional rickets. J Trop Pediatr 2014;60:203–10.10.1093/tropej/fmt105Search in Google Scholar PubMed

14. Soliman AT, Adel A, Wagdy M, Alali M, Aziz Bedair EM. Manifestations of severe vitamin D deficiency in adolescents: effects of intramuscular injection of a megadose of cholecalciferol. J Trop Pediatr 2011;57:303–6.10.1093/tropej/fmq028Search in Google Scholar PubMed

15. Khan AH, Rohra DK, Saghir SA, Udani SK, Wood R, et al. Response of a single ‘mega intramuscular dose’ of Vitamin D on Serum 25OHD and parathyroid hormone levels. J Coll Physicians Surg Pak 2012;22:207–12.Search in Google Scholar

16. Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005;183:10–2.10.5694/j.1326-5377.2005.tb06879.xSearch in Google Scholar PubMed

17. Ilahi M, Armas L, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008;87:688–91.10.1093/ajcn/87.3.688Search in Google Scholar PubMed

18. Goswami R, Gupta N, Ray D, Singh N, Tomar N. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D. Br J Nutr 2008;100:526–9.10.1017/S0007114508921711Search in Google Scholar PubMed

19. Emel T, Doğan DA, Erdem G, Faruk O. Therapy strategies in vitamin D deficiency with or without rickets: efficiency of low-dose stosstherapy. J Pediatr Endocrinol Metab 2012;25:107–10.10.1515/jpem-2011-0368Search in Google Scholar PubMed

20. Markestad T, Hesse V, Siebenhuner M, Jahreis G, Aksnes L, et al. Intermittent high-dose vitamin D prophylaxis during infancy: effect on vitamin D metabolites, calcium, and phosphorus. Am J Clin Nutr 1987;46:652–8.10.1093/ajcn/46.4.652Search in Google Scholar PubMed

21. Mittal H, Rai S, Shah D, Madhu SV, Mehrotra G, et al. 300,000 IU or 600,000 IU of oral vitamin D3 for treatment of nutritional rickets: a randomized controlled trial. Indian Pediatr 2014;51:265–72.10.1007/s13312-014-0399-7Search in Google Scholar PubMed

22. Sahay M, Sahay R. Rickets vitamin D deficiency and dependency. Indian J Endocrinol Metab 2012;16:164–76.10.4103/2230-8210.93732Search in Google Scholar PubMed PubMed Central

23. Paxton GA, Teale GR, Nowson CA, Mason RS, McGrath JJ, et al. Australian and New Zealand Bone and Mineral Society; Osteoporosis Australia. Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Med J Aust 2013;198:142–3.10.5694/mja11.11592Search in Google Scholar PubMed

24. Vogiatzi MG, Jacobson-Dickman E, DeBoer MD, and Drugs and Therapeutics Committee of The Pediatric Endocrine Society. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab 2014;99:1132–41.10.1210/jc.2013-3655Search in Google Scholar PubMed

Received: 2015-1-19
Accepted: 2015-12-30
Published Online: 2016-2-25
Published in Print: 2016-6-1

©2016 by De Gruyter

Downloaded on 26.4.2024 from https://www.degruyter.com/document/doi/10.1515/jpem-2015-0031/html
Scroll to top button